Structure

Physi-Chem Properties

Molecular Weight:  325.13
Volume:  324.737
LogP:  2.031
LogD:  2.326
LogS:  -2.839
# Rotatable Bonds:  1
TPSA:  51.16
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.873
Synthetic Accessibility Score:  3.637
Fsp3:  0.368
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.818
MDCK Permeability:  3.4516313462518156e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.08
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.991
Plasma Protein Binding (PPB):  88.12098693847656%
Volume Distribution (VD):  2.656
Pgp-substrate:  6.508467197418213%

ADMET: Metabolism

CYP1A2-inhibitor:  0.688
CYP1A2-substrate:  0.934
CYP2C19-inhibitor:  0.189
CYP2C19-substrate:  0.943
CYP2C9-inhibitor:  0.032
CYP2C9-substrate:  0.842
CYP2D6-inhibitor:  0.706
CYP2D6-substrate:  0.888
CYP3A4-inhibitor:  0.594
CYP3A4-substrate:  0.907

ADMET: Excretion

Clearance (CL):  13.732
Half-life (T1/2):  0.093

ADMET: Toxicity

hERG Blockers:  0.095
Human Hepatotoxicity (H-HT):  0.128
Drug-inuced Liver Injury (DILI):  0.153
AMES Toxicity:  0.561
Rat Oral Acute Toxicity:  0.582
Maximum Recommended Daily Dose:  0.812
Skin Sensitization:  0.141
Carcinogencity:  0.403
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.934

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC214116

Natural Product ID:  NPC214116
Common Name*:   Guatterine
IUPAC Name:   n.a.
Synonyms:   Guatterine
Standard InCHIKey:  IMMQQBXZSPYGID-HOTGVXAUSA-N
Standard InCHI:  InChI=1S/C19H19NO4/c1-20-8-7-12-13-14(18-19(17(12)22-2)24-9-23-18)10-5-3-4-6-11(10)16(21)15(13)20/h3-6,15-16,21H,7-9H2,1-2H3/t15-,16-/m0/s1
SMILES:  COc1c2OCOc2c2c3c1CCN([C@@H]3[C@H](c1c2cccc1)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL464733
PubChem CID:   10358947
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0000381] Aporphines
        • [CHEMONTID:0003021] Hydroxy-7-aporphines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4501 Caragana intermedia Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[15620236]
NPO24342 Lupinus albus Species Fabaceae Eukaryota Seed n.a. n.a. Database[FooDB]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. Database[FooDB]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO21816 Calea jamaicensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25164 Polyalthia suaveolens Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24593 Campanula pyramidalis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24561 Sesuvium portulacastrum Species Aizoaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25009 Cystoseira myrica Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4501 Caragana intermedia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24939 Veronica officinalis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13718 Poria tenuis Species Coccinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24123 Ramalina scopulorum Species Ramalinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12599.1 Pinus leiophylla var. chihuahuana Varieties Pinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28729 Spirostachys africana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14893 Streptomyces eurocidicus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO24723 Ophiorrhiza bracteata Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell Line Vero Chlorocebus aethiops CC50 = 107000.0 nM PMID[514738]
NPT189 Cell Line Vero Chlorocebus aethiops MTC = 62.0 uM PMID[514738]
NPT1859 Organism Human poliovirus 2 Human poliovirus 2 ED50 = 62.0 uM PMID[514738]
NPT2 Others Unspecified Ratio = 1.7 n.a. PMID[514738]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC214116 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9651 High Similarity NPC117717
0.9586 High Similarity NPC248642
0.9583 High Similarity NPC126284
0.9529 High Similarity NPC156576
0.9286 High Similarity NPC149090
0.9286 High Similarity NPC19520
0.9133 High Similarity NPC476575
0.9091 High Similarity NPC82763
0.9086 High Similarity NPC57036
0.907 High Similarity NPC114364
0.907 High Similarity NPC320223
0.9064 High Similarity NPC128560
0.9064 High Similarity NPC229166
0.9064 High Similarity NPC199465
0.9048 High Similarity NPC24264
0.9048 High Similarity NPC476432
0.9034 High Similarity NPC186546
0.9034 High Similarity NPC476576
0.9012 High Similarity NPC112575
0.9 High Similarity NPC118274
0.9 High Similarity NPC168753
0.8994 High Similarity NPC298979
0.8994 High Similarity NPC247389
0.8988 High Similarity NPC167546
0.8988 High Similarity NPC16805
0.8988 High Similarity NPC225774
0.8988 High Similarity NPC302527
0.8966 High Similarity NPC474506
0.8966 High Similarity NPC32413
0.896 High Similarity NPC148693
0.896 High Similarity NPC23219
0.896 High Similarity NPC118633
0.896 High Similarity NPC294790
0.8947 High Similarity NPC239775
0.8935 High Similarity NPC219341
0.8908 High Similarity NPC258695
0.8908 High Similarity NPC267408
0.8908 High Similarity NPC470879
0.8895 High Similarity NPC2314
0.8882 High Similarity NPC210918
0.882 High Similarity NPC237579
0.881 High Similarity NPC160298
0.881 High Similarity NPC232924
0.881 High Similarity NPC266753
0.881 High Similarity NPC306902
0.881 High Similarity NPC477559
0.8807 High Similarity NPC233718
0.8807 High Similarity NPC116284
0.88 High Similarity NPC244554
0.8772 High Similarity NPC150879
0.8757 High Similarity NPC135772
0.875 High Similarity NPC312918
0.875 High Similarity NPC476574
0.875 High Similarity NPC155442
0.875 High Similarity NPC477561
0.8736 High Similarity NPC477558
0.8693 High Similarity NPC474507
0.8686 High Similarity NPC476577
0.8686 High Similarity NPC173416
0.8686 High Similarity NPC148709
0.8671 High Similarity NPC6152
0.8663 High Similarity NPC205421
0.8663 High Similarity NPC117188
0.8663 High Similarity NPC158376
0.8663 High Similarity NPC12053
0.8663 High Similarity NPC474931
0.8663 High Similarity NPC81218
0.8663 High Similarity NPC145832
0.8663 High Similarity NPC306555
0.8655 High Similarity NPC136508
0.8655 High Similarity NPC212794
0.8655 High Similarity NPC196447
0.8655 High Similarity NPC13504
0.8655 High Similarity NPC306843
0.8655 High Similarity NPC96603
0.8655 High Similarity NPC253043
0.8655 High Similarity NPC78222
0.8655 High Similarity NPC477563
0.8619 High Similarity NPC475754
0.8596 High Similarity NPC275132
0.8596 High Similarity NPC233650
0.8596 High Similarity NPC324144
0.858 High Similarity NPC476572
0.8571 High Similarity NPC99659
0.8571 High Similarity NPC325871
0.8563 High Similarity NPC152212
0.8555 High Similarity NPC204947
0.8547 High Similarity NPC134858
0.8523 High Similarity NPC187678
0.8506 High Similarity NPC241055
0.85 High Similarity NPC9867
0.8497 Intermediate Similarity NPC304659
0.8497 Intermediate Similarity NPC86144
0.8488 Intermediate Similarity NPC1229
0.8483 Intermediate Similarity NPC220961
0.848 Intermediate Similarity NPC27410
0.848 Intermediate Similarity NPC166014
0.8457 Intermediate Similarity NPC75958
0.8448 Intermediate Similarity NPC210140
0.8439 Intermediate Similarity NPC169743
0.8439 Intermediate Similarity NPC168409
0.8409 Intermediate Similarity NPC477640
0.8409 Intermediate Similarity NPC470739
0.8409 Intermediate Similarity NPC225597
0.84 Intermediate Similarity NPC475686
0.84 Intermediate Similarity NPC266176
0.84 Intermediate Similarity NPC158148
0.84 Intermediate Similarity NPC82533
0.84 Intermediate Similarity NPC290759
0.84 Intermediate Similarity NPC58766
0.8393 Intermediate Similarity NPC326316
0.8393 Intermediate Similarity NPC81733
0.8391 Intermediate Similarity NPC13916
0.8391 Intermediate Similarity NPC264850
0.8382 Intermediate Similarity NPC189470
0.8372 Intermediate Similarity NPC119649
0.8372 Intermediate Similarity NPC235143
0.8372 Intermediate Similarity NPC205255
0.8372 Intermediate Similarity NPC230956
0.8372 Intermediate Similarity NPC271388
0.837 Intermediate Similarity NPC24260
0.837 Intermediate Similarity NPC478093
0.8362 Intermediate Similarity NPC477020
0.8362 Intermediate Similarity NPC66341
0.8362 Intermediate Similarity NPC192135
0.8352 Intermediate Similarity NPC477562
0.8352 Intermediate Similarity NPC474475
0.8352 Intermediate Similarity NPC26240
0.8352 Intermediate Similarity NPC69712
0.8343 Intermediate Similarity NPC190332
0.8343 Intermediate Similarity NPC181653
0.8333 Intermediate Similarity NPC46990
0.8333 Intermediate Similarity NPC232514
0.8333 Intermediate Similarity NPC276944
0.8333 Intermediate Similarity NPC24465
0.8333 Intermediate Similarity NPC238530
0.8324 Intermediate Similarity NPC79402
0.8324 Intermediate Similarity NPC30182
0.8324 Intermediate Similarity NPC473589
0.8324 Intermediate Similarity NPC478092
0.8324 Intermediate Similarity NPC80759
0.8324 Intermediate Similarity NPC478091
0.8314 Intermediate Similarity NPC221864
0.8287 Intermediate Similarity NPC299990
0.8287 Intermediate Similarity NPC73492
0.8286 Intermediate Similarity NPC68328
0.828 Intermediate Similarity NPC162653
0.8276 Intermediate Similarity NPC320104
0.8249 Intermediate Similarity NPC311991
0.8246 Intermediate Similarity NPC216459
0.8246 Intermediate Similarity NPC41178
0.8246 Intermediate Similarity NPC138487
0.8246 Intermediate Similarity NPC244112
0.8242 Intermediate Similarity NPC302275
0.8239 Intermediate Similarity NPC100566
0.8229 Intermediate Similarity NPC180306
0.8222 Intermediate Similarity NPC15919
0.8218 Intermediate Similarity NPC60186
0.8214 Intermediate Similarity NPC475959
0.8208 Intermediate Similarity NPC111485
0.8207 Intermediate Similarity NPC474904
0.8202 Intermediate Similarity NPC231371
0.8198 Intermediate Similarity NPC146288
0.8197 Intermediate Similarity NPC16357
0.8197 Intermediate Similarity NPC302245
0.8197 Intermediate Similarity NPC95426
0.8192 Intermediate Similarity NPC204908
0.8192 Intermediate Similarity NPC83198
0.8182 Intermediate Similarity NPC35627
0.8182 Intermediate Similarity NPC476573
0.8182 Intermediate Similarity NPC81247
0.8167 Intermediate Similarity NPC474470
0.8167 Intermediate Similarity NPC241704
0.8167 Intermediate Similarity NPC237044
0.8152 Intermediate Similarity NPC65312
0.8152 Intermediate Similarity NPC139783
0.814 Intermediate Similarity NPC123323
0.8122 Intermediate Similarity NPC474325
0.8111 Intermediate Similarity NPC304675
0.8111 Intermediate Similarity NPC329969
0.8108 Intermediate Similarity NPC22115
0.8108 Intermediate Similarity NPC275680
0.8108 Intermediate Similarity NPC312531
0.8107 Intermediate Similarity NPC37144
0.8107 Intermediate Similarity NPC59907
0.8105 Intermediate Similarity NPC475654
0.8103 Intermediate Similarity NPC59028
0.8103 Intermediate Similarity NPC477080
0.8103 Intermediate Similarity NPC92191
0.8101 Intermediate Similarity NPC65403
0.8092 Intermediate Similarity NPC126519
0.8092 Intermediate Similarity NPC203784
0.8092 Intermediate Similarity NPC170503
0.8092 Intermediate Similarity NPC31311
0.8092 Intermediate Similarity NPC234392
0.8079 Intermediate Similarity NPC124657
0.8079 Intermediate Similarity NPC56887
0.8079 Intermediate Similarity NPC223077
0.8079 Intermediate Similarity NPC193853
0.8077 Intermediate Similarity NPC32154

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC214116 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8352 Intermediate Similarity NPD7906 Approved
0.8297 Intermediate Similarity NPD4663 Approved
0.8286 Intermediate Similarity NPD3051 Approved
0.8239 Intermediate Similarity NPD2970 Approved
0.8239 Intermediate Similarity NPD2969 Approved
0.8232 Intermediate Similarity NPD4577 Approved
0.8232 Intermediate Similarity NPD4578 Approved
0.809 Intermediate Similarity NPD27 Approved
0.809 Intermediate Similarity NPD2489 Approved
0.7989 Intermediate Similarity NPD8054 Approved
0.7989 Intermediate Similarity NPD8053 Approved
0.7989 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD5241 Discontinued
0.7956 Intermediate Similarity NPD8156 Discontinued
0.7901 Intermediate Similarity NPD8251 Approved
0.7901 Intermediate Similarity NPD8099 Discontinued
0.7901 Intermediate Similarity NPD8252 Approved
0.7889 Intermediate Similarity NPD4481 Phase 3
0.7853 Intermediate Similarity NPD2974 Approved
0.7853 Intermediate Similarity NPD2973 Approved
0.7853 Intermediate Similarity NPD2975 Approved
0.7838 Intermediate Similarity NPD7311 Approved
0.7838 Intermediate Similarity NPD7312 Approved
0.7838 Intermediate Similarity NPD7313 Approved
0.7838 Intermediate Similarity NPD7310 Approved
0.7836 Intermediate Similarity NPD4584 Approved
0.7835 Intermediate Similarity NPD5005 Approved
0.7835 Intermediate Similarity NPD5006 Approved
0.7798 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD6788 Approved
0.7796 Intermediate Similarity NPD7309 Approved
0.7784 Intermediate Similarity NPD3450 Approved
0.7784 Intermediate Similarity NPD2493 Approved
0.7784 Intermediate Similarity NPD2494 Approved
0.7784 Intermediate Similarity NPD3452 Approved
0.7778 Intermediate Similarity NPD2420 Approved
0.7778 Intermediate Similarity NPD2421 Approved
0.7778 Intermediate Similarity NPD6071 Discontinued
0.774 Intermediate Similarity NPD2563 Approved
0.774 Intermediate Similarity NPD2560 Approved
0.7732 Intermediate Similarity NPD4580 Approved
0.772 Intermediate Similarity NPD4420 Approved
0.7719 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD2977 Approved
0.7684 Intermediate Similarity NPD2978 Approved
0.7667 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD4582 Approved
0.7665 Intermediate Similarity NPD4583 Approved
0.7614 Intermediate Similarity NPD4004 Approved
0.7614 Intermediate Similarity NPD4002 Approved
0.7598 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7827 Phase 1
0.7558 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2488 Approved
0.75 Intermediate Similarity NPD2490 Approved
0.75 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD4773 Phase 2
0.7472 Intermediate Similarity NPD4772 Phase 2
0.7463 Intermediate Similarity NPD7047 Phase 3
0.746 Intermediate Similarity NPD2971 Approved
0.746 Intermediate Similarity NPD2968 Approved
0.7459 Intermediate Similarity NPD7831 Phase 2
0.7459 Intermediate Similarity NPD7833 Phase 2
0.7459 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD4055 Discovery
0.7458 Intermediate Similarity NPD4005 Discontinued
0.7442 Intermediate Similarity NPD4237 Approved
0.7442 Intermediate Similarity NPD4236 Phase 3
0.7436 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD6997 Phase 2
0.7411 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD2898 Approved
0.736 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD5177 Phase 3
0.7306 Intermediate Similarity NPD7243 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7213 Phase 3
0.7273 Intermediate Similarity NPD7212 Phase 2
0.7263 Intermediate Similarity NPD4017 Approved
0.7259 Intermediate Similarity NPD5582 Discontinued
0.7247 Intermediate Similarity NPD4727 Phase 1
0.7241 Intermediate Similarity NPD3060 Approved
0.7238 Intermediate Similarity NPD7298 Approved
0.7238 Intermediate Similarity NPD37 Approved
0.7232 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD1424 Approved
0.7232 Intermediate Similarity NPD7447 Phase 1
0.7222 Intermediate Similarity NPD4678 Approved
0.7222 Intermediate Similarity NPD4675 Approved
0.7209 Intermediate Similarity NPD1753 Discontinued
0.7204 Intermediate Similarity NPD4010 Discontinued
0.7196 Intermediate Similarity NPD6042 Phase 2
0.7196 Intermediate Similarity NPD42 Phase 2
0.7189 Intermediate Similarity NPD5677 Discontinued
0.7174 Intermediate Similarity NPD5604 Discontinued
0.7151 Intermediate Similarity NPD6030 Approved
0.7151 Intermediate Similarity NPD6031 Approved
0.715 Intermediate Similarity NPD8095 Phase 1
0.7135 Intermediate Similarity NPD7549 Discontinued
0.7135 Intermediate Similarity NPD7400 Phase 3
0.7135 Intermediate Similarity NPD5709 Phase 3
0.7129 Intermediate Similarity NPD3057 Approved
0.7123 Intermediate Similarity NPD7907 Approved
0.712 Intermediate Similarity NPD6297 Approved
0.712 Intermediate Similarity NPD4966 Approved
0.712 Intermediate Similarity NPD4965 Approved
0.712 Intermediate Similarity NPD4967 Phase 2
0.7119 Intermediate Similarity NPD3845 Phase 1
0.7119 Intermediate Similarity NPD7124 Phase 2
0.7119 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD6723 Discontinued
0.711 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD4111 Phase 1
0.7109 Intermediate Similarity NPD4665 Approved
0.7104 Intermediate Similarity NPD5772 Approved
0.7104 Intermediate Similarity NPD5773 Approved
0.7098 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD4666 Phase 3
0.708 Intermediate Similarity NPD8153 Approved
0.708 Intermediate Similarity NPD8152 Approved
0.7076 Intermediate Similarity NPD3109 Approved
0.7076 Intermediate Similarity NPD3110 Approved
0.7062 Intermediate Similarity NPD6853 Approved
0.7062 Intermediate Similarity NPD6851 Approved
0.7059 Intermediate Similarity NPD6107 Approved
0.7056 Intermediate Similarity NPD3640 Phase 3
0.7056 Intermediate Similarity NPD3641 Approved
0.7056 Intermediate Similarity NPD3639 Approved
0.7056 Intermediate Similarity NPD5976 Discontinued
0.7047 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD6674 Discontinued
0.7044 Intermediate Similarity NPD3533 Approved
0.7044 Intermediate Similarity NPD2972 Approved
0.7032 Intermediate Similarity NPD6625 Approved
0.7031 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD4721 Approved
0.7029 Intermediate Similarity NPD4725 Approved
0.7029 Intermediate Similarity NPD4726 Approved
0.7019 Intermediate Similarity NPD5676 Approved
0.701 Intermediate Similarity NPD7281 Phase 3
0.701 Intermediate Similarity NPD7280 Phase 3
0.7006 Intermediate Similarity NPD7466 Approved
0.7 Intermediate Similarity NPD6090 Discontinued
0.6995 Remote Similarity NPD6072 Discontinued
0.6977 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6977 Remote Similarity NPD2238 Phase 2
0.6976 Remote Similarity NPD4040 Phase 1
0.6966 Remote Similarity NPD5160 Discontinued
0.6963 Remote Similarity NPD7228 Approved
0.6961 Remote Similarity NPD3448 Approved
0.6961 Remote Similarity NPD2491 Approved
0.6957 Remote Similarity NPD3383 Approved
0.6957 Remote Similarity NPD3384 Approved
0.6957 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6957 Remote Similarity NPD3382 Approved
0.6954 Remote Similarity NPD6842 Approved
0.6954 Remote Similarity NPD6841 Approved
0.6954 Remote Similarity NPD6843 Phase 3
0.6954 Remote Similarity NPD2200 Suspended
0.6952 Remote Similarity NPD6234 Discontinued
0.6946 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4107 Approved
0.6944 Remote Similarity NPD4123 Phase 3
0.6943 Remote Similarity NPD7007 Discovery
0.6937 Remote Similarity NPD7048 Phase 3
0.6927 Remote Similarity NPD6666 Approved
0.6927 Remote Similarity NPD6667 Approved
0.6914 Remote Similarity NPD4108 Discontinued
0.6911 Remote Similarity NPD5602 Clinical (unspecified phase)
0.691 Remote Similarity NPD5754 Discontinued
0.6901 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6895 Remote Similarity NPD5242 Approved
0.6893 Remote Similarity NPD7037 Approved
0.6878 Remote Similarity NPD7802 Discontinued
0.6875 Remote Similarity NPD7701 Phase 2
0.686 Remote Similarity NPD5718 Phase 2
0.6854 Remote Similarity NPD4162 Approved
0.6834 Remote Similarity NPD7235 Clinical (unspecified phase)
0.6831 Remote Similarity NPD4210 Discontinued
0.6829 Remote Similarity NPD4482 Phase 3
0.6828 Remote Similarity NPD4585 Approved
0.6825 Remote Similarity NPD6037 Discontinued
0.6823 Remote Similarity NPD5938 Phase 3
0.6821 Remote Similarity NPD4474 Approved
0.6821 Remote Similarity NPD554 Clinical (unspecified phase)
0.6821 Remote Similarity NPD4475 Approved
0.6816 Remote Similarity NPD7262 Phase 1
0.6811 Remote Similarity NPD5089 Approved
0.6811 Remote Similarity NPD5090 Approved
0.6806 Remote Similarity NPD6688 Approved
0.6806 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6806 Remote Similarity NPD6687 Approved
0.6802 Remote Similarity NPD3027 Phase 3
0.6802 Remote Similarity NPD5155 Approved
0.6802 Remote Similarity NPD5156 Approved
0.68 Remote Similarity NPD2568 Approved
0.68 Remote Similarity NPD3808 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data